Strait of Hormuz, Rate Hikes, and Week Review
Strait of Hormuz tensions and hawkish central banks shaped the week. Our agent reviews all seven research subjects, Samsung's exit, and what to watch next.
Strait of Hormuz, Rate Hikes, and Week Review
The last time conditions loosely resembled this past week was Q4 2018, when the Fed was tightening into softening data while geopolitical uncertainty amplified the mood swings. Back then, the S&P 500 fell roughly 14% over the quarter on a close-to-close basis, with a peak-to-trough drawdown closer to 20%, before reversing sharply once the Fed pivoted. I keep coming back to this parallel, and as I noted in the [Weekly Review: Defensive Rotation, Samsung Exit, and Iran Sanctions Relief](/blog/weekly-review-defensive-rotation-samsung-exit-june-2026
Strait of Hormuz, Rate Hikes, and Week Review
The last time conditions loosely resembled this past week was Q4 2018, when the Fed was tightening into softening data while geopolitical uncertainty amplified the mood swings. Back then, the S&P 500 fell roughly 14% over the quarter on a close-to-close basis, with a peak-to-trough drawdown closer to 20%, before reversing sharply once the Fed pivoted. I keep coming back to this parallel, and as I noted in the Weekly Review: Defensive Rotation, Samsung Exit, and Iran Sanctions Relief post, the rhyme is imperfect but the rhythm is similar: a central bank leaning hawkish while a geopolitical situation scrambles the risk calculus underneath.
This Sunday morning, with markets closed, feels like a good moment to step back and sort through what this week actually told us.
The Week's Dominant Tension: Energy Security Meets Monetary Tightening
Two forces pulled markets in opposite directions all week, and neither resolved by Friday's close.
First, the Strait of Hormuz. Iran claimed it closed the waterway, the U.S. disputed that claim, and ships began trickling through after what headlines describe as months of near-total closure. Vice President Vance headed to Switzerland to meet an Iranian delegation, with nuclear issues and renewed fighting in Lebanon topping the agenda. Adding pressure to the diplomatic picture, the Wall Street Journal reported this week that U.S. sanctions continue to struggle to curb evasion tactics by Iran, Russia, and North Korea, a reminder that even when diplomatic frameworks exist, enforcement gaps limit their effectiveness. Separately, Israel said it eliminated two Hamas and Islamic Jihad operatives tied to a major funding network, widening the regional instability lens that keeps the energy security premium elevated. One of the week's most telling headlines framed it simply: energy security, not climate goals, is now driving the clean power boom. The effects of this year's energy crisis are not going away quickly, even if diplomatic progress materializes.
Second, rate expectations tightened further. The Fed's preferred inflation gauge reportedly showed faster inflation, reinforcing consensus around the need for rate hikes this year. Separately, Bank of America flagged the possibility that the ECB may hike rates again despite weak growth. This is the kind of policy environment that puts pressure on valuations broadly, with longer-duration assets feeling it most.
These two forces, energy-driven inflation risk and hawkish central bank responses, are not independent. Hormuz disruption feeds into commodity prices, which feed into the inflation data the Fed watches, which in turn reinforces the hawkish stance. That feedback loop is part of what made this week so difficult for risk assets.
By the close of Friday's session, the S&P 500 index had pulled back 1.21%. The Nasdaq Composite fell 1.34%. The Dow dropped 0.98%. Notably, the FTSE 100 fell 1.38% and Australia's ASX 200 lost 1.53%, suggesting the risk-off mood was global, not just a U.S. phenomenon. Meanwhile, the VIX rose 12.37% to 18.44, elevated but not panicked. The 10-year Treasury yield sat at 4.451%, while the 30-year was at 4.901%. These are not crisis-level numbers, but they describe a market that is repricing risk rather than ignoring it.
A technical note for data-focused readers: the S&P 500 index (^GSPC) registered a weekly change of -1.21%, while the SPY ETF showed a positive weekly change. This apparent discrepancy likely reflects differing measurement windows and the impact of dividends or rebalancing flows in the ETF wrapper. The index-level return is the cleaner read for weekly market direction.
As I discussed in Iran Talks Stall, Oil Outlook Clouds, and US Stocks Pull Back, the combination of stalled diplomacy and hawkish monetary signals creates a difficult backdrop for risk assets. That dynamic only deepened this week.
What the Agent Got Right, and Where Reality Pushed Back
Let me start with the clear positive observed outcome. The agent closed its Samsung (005930.KS) research subject this week at a 20.3% gain after the stock hit its automated exit level. Samsung was a textbook case of what the agent does best, according to our research history: identifying extreme valuation dislocations in semiconductor names with triple-digit earnings growth and a forward PE well below 8x. Five of the agent's top six wins have come from this exact setup. Closing Samsung at over 20% in a relatively short window confirms that pattern once more. South Korea's KOSPI index rose 2.12% this week, providing a constructive backdrop for that exit.
Now the honest part. Several active research subjects are underwater, and the week did not help most of them.
MSFT sits at $379.40, down 2.9% from entry. The thesis around Microsoft as a high-quality compounder trading at a meaningful discount remains intact per the agent's review, rated 5 out of 5 on thesis health. But a hawkish Fed backdrop and elevated geopolitical risk are exactly the conditions that delay re-rating for growth names. A specific pressure point emerged this week: Accenture's Q3 FY26 earnings revealed margin gains offset by a revenue miss, sending its stock plunging. Large-cap IT services weakness of this kind tends to spill over into sentiment for the broader enterprise tech complex, creating a headwind for names like Microsoft even when their own fundamentals are intact.
ADBE is down 4.34% from entry at $195.16. Adobe's thesis, centered on an extreme valuation dislocation for a company with strong profitability, also holds at full health. The market continues to price in severe AI disruption risk. The agent flagged this as a deep value setup, and the word "deep" is doing a lot of work right now. The Accenture miss only reinforced the market's skepticism about enterprise software pricing power in an AI-disrupted landscape. This is one of the higher-risk research subjects, and the current environment is not kind to it.
META at $577.22 is off 2.66% from its entry. The thesis here, a profitable mega-cap with a PEG ratio well below 1.0, scored full marks on its latest review. But as the agent's research history has shown, high-beta growth names get hit disproportionately in risk-off weeks driven by geopolitical catalysts. The Nasdaq Composite's 1.34% decline reflects exactly this dynamic: when the VIX jumps 12% in a week, capital rotates out of higher-beta names first.
LLY, Eli Lilly, is down 3.04% at $1,098.57. This is the agent's one healthcare subject, and it matters that it is the only type of healthcare position the agent's track record supports: hypergrowth revenue and earnings, not a slow-growth dividend play. GLP-1 demand is a secular story, and the thesis remains healthy at 5 out of 5. But even secular growth stories get caught in broad risk-off moves when rising rates pressure all long-duration equity valuations.
Where the Defensive Thesis Is Working
PG, Procter and Gamble, is the standout this week. It gained 2.74% from entry, sitting at $150.56. The defensive rotation thesis, that quality consumer staples gain relative strength in geopolitical risk-off environments, is doing what it was designed to do. In a week where the S&P 500 fell over a percent, PG held up. Its thesis health is rated 5 out of 5. The cause and effect here is straightforward: when Hormuz headlines and hawkish Fed signals combine to push the VIX up 12%, capital seeks predictable cash flows, and PG offers exactly that.
XLF, the Financial Select Sector ETF, is also showing positive delta at 2.43% from entry, currently at $53.57. The steepening yield curve dynamic and solid bank earnings growth that underpinned this thesis continue to hold. The agent's thesis review maintained it at full health, and the relative outperformance versus the broader market since entry supports the original read.
IWM, the Russell 2000 small-cap ETF, is up 3.67% from entry at $295.59. The Russell 2000 index (^RUT) dipped 0.72% for the week, a smaller decline than the large-cap benchmarks, while the IWM ETF itself registered a positive weekly change. This is the one research subject flagged with minor concerns by the thesis review system, rated 4 out of 5. The risk the review identified remains relevant: if the tech selloff broadens into a general risk-off move, small caps with weaker balance sheets are vulnerable. IWM is still in positive territory from entry, but the agent is watching this one closely. The confidence on this entry was just 43%, well below the 60% threshold that the agent's own research history identifies as a near-100% loss zone for individual stocks. For ETFs used as beta proxies, the agent has seen lower-confidence entries work, but the margin for error is thin.
The Lesson This Week Taught
Defensive rotation is not just a buzzword. It is a measurable, observable phenomenon that shows up in the data when geopolitical risk and monetary tightening coincide. PG outperformed the S&P 500 by several percentage points this week, and XLF held up better than the broader market, because capital rotates toward predictable earnings when the Strait of Hormuz and Fed hawkishness dominate the headlines simultaneously. The Samsung exit, meanwhile, is a reminder that the agent's best wins come from patiently entering extreme valuation dislocations and letting the math close the gap.
The tension between these two lessons is worth sitting with. Extreme dislocations like ADBE and MSFT require patience and a tolerance for drawdowns, and patience is harder to maintain when the VIX is climbing and central banks are tightening. The Accenture miss illustrates how quickly sentiment can shift against an entire sector when one bellwether disappoints.
What Stays With Us Going Into Next Week
The U.S.-Iran talks in Switzerland, beginning today, are the single most important catalyst on the near-term horizon. If they produce even a framework for Strait of Hormuz normalization, the energy security premium that has been embedded in everything from oil to equities could shift meaningfully. If they stall again, or if the sanctions enforcement gaps the WSJ highlighted this week undermine credibility, the risk-off rotation that favored PG and XLF this week will likely continue, and the growth names the agent is studying, MSFT, META, ADBE, LLY, will face more headwinds before their fundamental cases can reassert themselves.
The broader Middle East picture matters too. Israel's operations against Hamas and Islamic Jihad funding networks, combined with renewed fighting in Lebanon, mean the regional instability that feeds energy risk premiums has multiple potential escalation points beyond just the Hormuz negotiations.
I will be watching the Hormuz headlines closely. And honestly, I will be watching whether IWM holds its gains or whether the minor concerns the thesis review flagged start to materialize more concretely.
A reminder: everything above is observational research, not personalized advice. The agent studies subjects; it does not manage your money. Please consult an authorized financial advisor before any investment decision.
Research output, not investment advice. The material above is observational and educational. The operator of Observed Markets may hold personal positions in subjects the agent studies (disclosed at observedmarkets.com/conflicts-of-interest). Always consult an authorized financial advisor before any investment decision. Past observed outcomes do not predict future results.